News

Emcure Pharmaceuticals faces a total Rs 57.74 crore income tax penalty for FY2014-15 to FY2020-21 and is evaluating legal options to appeal the orders.

Income Tax Department Imposes Rs 57.74 Crore Penalties on Emcure Pharmaceuticals for Seven Financial Years

Articles

Pharmaceuticals, textiles, footwear, fertilisers, renewable energy and EV sectors may seek relief from accumulated ITC arising from persistent inverted duty structures under GST.

GST Reform: Pharma, Textiles, EVs and Other Sectors Seek Relief from Accumulated ITC

Emcure Pharmaceuticals has received multiple orders levying an aggregate penalty amounting to Rs 57.73 crore for the FYs 2014-15 to 2020-21.

Emcure Pharmaceuticals Receives Multiple Income Tax Orders Imposing Rs 57.73 Crore Penalty; Company Evaluates Legal Remedies

Judgement

ITAT deletes AMP transfer pricing adjustment absent agreement with foreign associated enterprises.

ITAT Restores Section 35(2AB) Deduction to Cadila Pharmaceuticals

Orders

GST authorities levy penalty of Rs 41,33,84,165 on Torrent Pharmaceuticals Limited for export refund discrepancy.

Torrent Pharmaceuticals Gets Rs 41.33 Crore Central GST Penalty for Export Refund Discrepancy

Emcure Pharmaceutical Limited was charged under Section 441 of the Companies Act, 2013, regarding compounding of an offence under Section 152 of the Act.

Explore Our Blogs

Stay updated with the latest insights, tips, and industry trends from our experts

Income Tax Department Imposes Rs 57.74 Crore Penalties on Emcure Pharmaceuticals for Seven Financial Years

GST Reform: Pharma, Textiles, EVs and Other Sectors Seek Relief from Accumulated ITC

Emcure Pharmaceuticals Receives Multiple Income Tax Orders Imposing Rs 57.73 Crore Penalty; Company Evaluates Legal Remedies

ITAT Restores Section 35(2AB) Deduction to Cadila Pharmaceuticals

Torrent Pharmaceuticals Gets Rs 41.33 Crore Central GST Penalty for Export Refund Discrepancy

Emcure Pharmaceuticals Fined by MCA for 2015 Compliance Lapse